# CASUS: Validation for Detection of Precursor Lesions

> **NCT04530201** · NA · COMPLETED · sponsor: **Universiteit Antwerpen** · enrollment: 332 (actual)

## Conditions studied

- Cervical Cancer
- Cervical Intraepithelial Neoplasia
- Human Papilloma Virus
- HPV-Related Cervical Carcinoma
- Urine

## Interventions

- **DEVICE:** Colli-Pee Small Volumes (10 mL) device

## Key facts

- **NCT ID:** NCT04530201
- **Lead sponsor:** Universiteit Antwerpen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-20
- **Primary completion:** 2021-10-20
- **Final completion:** 2022-02-28
- **Target enrollment:** 332 (ACTUAL)
- **Last updated:** 2022-06-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04530201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04530201, "CASUS: Validation for Detection of Precursor Lesions". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04530201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*